Fergus Fleming - 01 Jul 2023 Form 3 Insider Report for Renalytix plc (RNLXY)

Reporting relationship: Chief Technical Officer, Director
Issuer ticker: RNLXY
Reported as of: 01 Jul 2023
Net transaction value: $0
SEC form: 3
Accepted by SEC: 03 Jul 2023, 16:20:15 UTC
Next SEC filing: 07 Jul 2023
Source filing: View source filing
Reporting owner signature: /s/ Katie Kazem, Attorney-in-Fact

Key filing fact

Fergus Fleming filed Form 3 for Renalytix plc (RNLXY) on 03 Jul 2023.

Key facts

This page summarizes Fergus Fleming's Form 3 filing for Renalytix plc (RNLXY).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Jul 2023, 16:20.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RNLX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 569,481
Date: 01 Jul 2023
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RNLX holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jul 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 538,161
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each representing two Ordinary Shares.

Footnote F2

Fully vested and exercisable.

Footnote F3

The exercise price is 1.21 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.53 using the Bank of England rate as of June 29, 2023 (1.00 pound sterling = $1.262).

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney